Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAND study of renin-angiotensin system inhibition in hyperfiltering homozygous sickle cell patients with albuminuria
2009-017091-25Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ramipril and irbesartan in sickle cell disease (SCD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in microalbuminuria or macroalbuminuria. Started May 2010; status: active.
02
Drugs
ramiprilirbesartan
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on 2009-017091-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017091-25.